The Blue Jays are heading into another offseason where the market could tempt them in plenty of directions, but not every name carrying a shiny projection deserves a serious look. Spotrac’s projected Annual Average Values for the upcoming free-agent class point to several fits for Toronto, including Tarik Skubal and Adrian Morejon. But there are also a few targets the Jays would be wise to pass on if the asking price lands where it’s currently projected.
Robbie Ray sits at the top of that caution list with a projected $23.8 million AAV. There’s obvious familiarity there, and a return to Toronto would come with the memory of the Cy Young season he once delivered.
But the numbers from his recent run tell a tougher story. He posted a 3.08 ERA in 122.2 innings with the Giants before being dealt to the Padres, where that mark jumped to 5.02 over 43 innings.
His FIP was higher with both clubs, which suggests the results outpaced the underlying performance. His fastball has also backed up to 93 mph from 94.8 mph in his previous stint with Toronto, and his strikeout rate fell to 19.9% in 2026 after sitting at 32.1% in 2021.
At 35, and with injury and age already working against him, more than $20 million per year looks steep.
Luis Arraez is another name that could make sense on paper but gets hard to justify at $18 million AAV. His bat-to-ball ability is elite, and that part of his game has never been in question.
He’s a career .316 hitter with a tiny 5.8% strikeout rate and no real power to speak of, reflected in a .098 ISO. He also turned in the best defensive season of his career in 2026, logging 12 OAA at second base.
Still, the Blue Jays need more punch, and Arraez doesn’t provide it. His defensive improvement also has to hold up over time for the price to make sense.
If Toronto is spending that kind of money, Jazz Chisholm or Brandon Lowe would be stronger bets.
Seiya Suzuki is the most expensive name in the group at a projected $27.5 million AAV. He’s one of the better outfielders available and comes off one of his strongest offensive seasons, along with the best defensive year of his career.
His 4.6 fWAR was a career high, and that’s the kind of production that will earn him a healthy payday. The fit with Toronto is real.
So are the warning signs. His bat speed held steady, but the quality of contact slipped: his barrel rate was 10.7%, the second-lowest of his career, his hard-hit rate dipped to a career-low 38.9%, and his max exit velocity was also among his weakest marks.
Like Arraez, the defensive gains need more proof before the Blue Jays pay that kind of premium. If they believe he can keep producing 4.0 fWAR seasons, then the price becomes easier to stomach.
If not, they may have to look elsewhere, possibly at fellow countryman Teruaki Sato.
Jason Adam rounds out the list at $8.7 million AAV, and even that number may be too rich for Toronto’s comfort. Relief pitching is always tricky, and the Blue Jays have recently shown a willingness to give multi-year deals to bullpen arms like Jeff Hoffman and Tyler Rogers.
Adam, though, doesn’t look like the kind of reliever who should be getting that treatment. He posted a 2.62 ERA in 34.1 innings last season, but the deeper numbers don’t back up the surface line.
His 4.85 FIP and 11.6 HR/FB rate point to a pitcher who benefited from some good fortune. His strikeout rate has declined every year since 2023 and dropped to a career-low 15.5% in 2026, while his fastball velocity fell to 93.4 mph.
Toronto does need another arm if it decides to move Spencer Miles into the rotation, but Adam shouldn’t be near the top of the list, even on a one-year deal.
The Blue Jays will have plenty to sort through this winter, and some names will look more appealing in theory than they do at their projected prices. For Toronto, these four look more like fallback options than priority targets.
In Other News...
Blue Jays Still Have One Major Rotation Question Heading Into 2027
Bowden Francis was one of the more encouraging pitching stories for Toronto late in 2024, when he settled into the rotation and gave the club a much-needed lift down the stretch. The right-handers rise had the look of a possible long-term answer, the kind of development that can quietly stabilize a staff and buy a team time as it sorts out the rest of its pitching depth.
Instead, his path has gone in a far different direction. Shoulder discomfort slowed him in 2025, and after Tommy John surgery in February 2026 he missed the entire season, leaving Toronto to wait on a recovery that is still unfolding as the calendar turns toward 2027. For a Blue Jays rotation trying to plan ahead, the biggest question is not what Francis looked like at his peak, but when he might be back on a mound at all. [Read more 🡒]
Kevin Gausman Is Closing Another Major Blue Jays Chapter
Kevin Gausmans Blue Jays run already ended on the field, but he is now closing another piece of his Toronto chapter off it. The veteran right-hander has put his Lawrence Park home on the market after spending the final season of his contract with the club before being moved elsewhere, a reminder that his time with the Blue Jays is now firmly in the rearview mirror.
The residence was part of the life he built while pitching in Toronto, and its sale fits the reality of a player moving on after a notable stint with a new team. Gausman has spoken positively about his time with the Blue Jays even after the trade, and this latest move suggests the separation from Toronto is becoming complete in every sense. [Read more 🡒]